CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade DENTSPLY SIRONA Inc. - XRAY CFD

33.96
0.21%
Market Trading Hours* (UTC) Open now
Closes on Thursday at 20:00

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.12
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026151 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026151%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003929 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003929%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

DENTSPLY SIRONA Inc ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 34.04
Open* 34.1
1-Year Change* 16.3%
Day's Range* 33.8 - 34.23
52 wk Range 26.48-43.24
Average Volume (10 days) 1.27M
Average Volume (3 months) 30.37M
Market Cap 7.66B
P/E Ratio -100.00K
Shares Outstanding 211.72M
Revenue 3.94B
EPS -4.77
Dividend (Yield %) 1.54867
Beta 0.98
Next Earnings Date Nov 13, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Sep 27, 2023 34.04 -0.27 -0.79% 34.31 34.79 33.69
Sep 26, 2023 34.51 0.77 2.28% 33.74 34.70 33.54
Sep 25, 2023 34.10 0.39 1.16% 33.71 34.13 33.62
Sep 22, 2023 33.79 -0.19 -0.56% 33.98 34.17 33.55
Sep 21, 2023 34.09 -0.41 -1.19% 34.50 34.85 33.98
Sep 20, 2023 35.12 -0.06 -0.17% 35.18 35.78 35.04
Sep 19, 2023 35.22 0.23 0.66% 34.99 35.58 34.99
Sep 18, 2023 35.47 0.19 0.54% 35.28 35.59 34.92
Sep 15, 2023 35.49 0.21 0.60% 35.28 36.04 34.84
Sep 14, 2023 35.52 -0.15 -0.42% 35.67 36.27 35.30
Sep 13, 2023 35.71 -0.75 -2.06% 36.46 36.50 35.68
Sep 12, 2023 36.60 0.53 1.47% 36.07 36.79 35.99
Sep 11, 2023 36.52 0.58 1.61% 35.94 36.74 35.81
Sep 8, 2023 35.93 0.04 0.11% 35.89 36.20 35.83
Sep 7, 2023 36.09 -0.52 -1.42% 36.61 36.70 36.02
Sep 6, 2023 36.64 0.21 0.58% 36.43 36.84 36.15
Sep 5, 2023 36.62 -0.50 -1.35% 37.12 37.22 36.52
Sep 1, 2023 37.43 0.21 0.56% 37.22 37.45 37.11
Aug 31, 2023 37.05 -0.22 -0.59% 37.27 37.63 37.01
Aug 30, 2023 37.27 -0.24 -0.64% 37.51 37.75 37.11

DENTSPLY SIRONA Inc. Events

Time (UTC) Country Event
Monday, November 13, 2023

Time (UTC)

13:30

Country

US

Event

Q3 2023 DENTSPLY SIRONA Inc Earnings Release
Q3 2023 DENTSPLY SIRONA Inc Earnings Release

Forecast

-

Previous

-
Monday, February 26, 2024

Time (UTC)

13:30

Country

US

Event

Q4 2023 DENTSPLY SIRONA Inc Earnings Release
Q4 2023 DENTSPLY SIRONA Inc Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 3922 4231 3339 4022 3986.3
Revenue 3922 4231 3339 4022 3986.3
Cost of Revenue, Total 1795 1887 1639 1833 1918.5
Gross Profit 2127 2344 1700 2189 2067.8
Total Operating Expense 4862 3623 3342 3670 4944.4
Selling/General/Admin. Expenses, Total 1589 1545 1300 1564 1558.6
Research & Development 174 171 123 143 160.5
Unusual Expense (Income) 1304 20 280 130 1306.8
Operating Income -940 608 -3 352 -958.1
Interest Income (Expense), Net Non-Operating -107 -49 -33 0 -30.6
Other, Net -8 -14 -14 -14 30.3
Net Income Before Taxes -1055 545 -50 338 -958.4
Net Income After Taxes -950 411 -73 256 -1015
Minority Interest 0 0 0 0 -0.1
Equity In Affiliates
Net Income Before Extra. Items -950 411 -73 256 -1015.1
Net Income -950 411 -73 256 -1011
Income Available to Common Excl. Extra. Items -950 411 -73 256 -1015.1
Income Available to Common Incl. Extra. Items -950 411 -73 256 -1011
Diluted Net Income -950 411 -73 256 -1011
Diluted Weighted Average Shares 215.5 220.2 219.2 224.4 224.3
Diluted EPS Excluding Extraordinary Items -4.40835 1.86649 -0.33303 1.14082 -4.52564
Dividends per Share - Common Stock Primary Issue 0.5 0.43 0.4 0.375 0.35
Diluted Normalized EPS -0.47517 1.93498 0.49726 1.5796 -0.67258
Total Extraordinary Items 4.1
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 1028 978 983 947 1023
Revenue 1028 978 983 947 1023
Cost of Revenue, Total 478 455 466 439 442
Gross Profit 550 523 517 508 581
Total Operating Expense 948 980 921 2165 904
Selling/General/Admin. Expenses, Total 416 416 402 401 410
Research & Development 49 46 43 41 45
Unusual Expense (Income) 5 63 10 1284 7
Operating Income 80 -2 62 -1218 119
Interest Income (Expense), Net Non-Operating -32 -23 -53 -21 -25
Other, Net -2 -3 -1 -2 -3
Net Income Before Taxes 46 -28 8 -1241 91
Net Income After Taxes 85 -23 -15 -1077 73
Minority Interest 1 4 0 0 0
Net Income Before Extra. Items 86 -19 -15 -1077 73
Net Income 86 -19 -15 -1077 73
Income Available to Common Excl. Extra. Items 86 -19 -15 -1077 73
Income Available to Common Incl. Extra. Items 86 -19 -15 -1077 73
Diluted Net Income 86 -19 -15 -1077 73
Diluted Weighted Average Shares 213.1 214.5 215.2 214.9 215.3
Diluted EPS Excluding Extraordinary Items 0.40357 -0.08858 -0.0697 -5.01163 0.33906
Dividends per Share - Common Stock Primary Issue 0.14 0.14 0.125 0.125 0.125
Diluted Normalized EPS 0.41882 0.10233 -0.0395 -1.12797 0.36514
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 1893 1852 1798 1999.9 1888
Cash and Short Term Investments 365 339 438 404.9 309.6
Cash & Equivalents 365 339 438 404.9 309.6
Total Receivables, Net 685 750 667 782 701.9
Accounts Receivable - Trade, Net 632 750 667 782 701.9
Total Inventory 627 515 476 561.7 598.9
Prepaid Expenses 128 248 150 121.7 133
Other Current Assets, Total 88 67 129.6 144.6
Total Assets 7643 9239 9350 8602.9 8687
Property/Plant/Equipment, Total - Net 961 971 967 961.7 870.6
Goodwill, Net 2688 3976 3986 3396.5 3431.3
Intangibles, Net 1903 2319 2504 2176.3 2420.3
Long Term Investments
Other Long Term Assets, Total 198 121 95 68.5 76.8
Total Current Liabilities 1170 1261 1372 995.5 1013.3
Accounts Payable 279 262 302 307.9 283.9
Accrued Expenses 624 760 627 594.4 546.8
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 118 182 299 2.3 92.4
Other Current Liabilities, Total 149 57 144 90.9 90.2
Total Liabilities 3832 4243 4418 3510.4 3565.9
Total Long Term Debt 1826 1913 1978 1433.1 1564.9
Long Term Debt 1825 1913 1977 1431.8 1564.9
Deferred Income Tax 287 391 381 479.6 552.8
Minority Interest 1 1 3 2.4 11.9
Other Liabilities, Total 548 677 684 599.8 423
Total Equity 3811 4996 4932 5092.5 5121.1
Common Stock 3 3 3 2.6 2.6
Additional Paid-In Capital 6629 6606 6604 6586.7 6522.3
Retained Earnings (Accumulated Deficit) 456 1514 1198 1404.2 1225.9
Treasury Stock - Common -2649 -2535 -2409 -2301.3 -2151
Other Equity, Total -628 -592 -464 -599.7 -478.7
Total Liabilities & Shareholders’ Equity 7643 9239 9350 8602.9 8687
Total Common Shares Outstanding 215.3 217.4 218.7 221.3 223
Property/Plant/Equipment, Total - Gross 2273 2359 2194.3 2076.8
Accumulated Depreciation, Total -1312 -1392 -1232.6 -1206.2
Unrealized Gain (Loss) 0
Capital Lease Obligations 1 1 1.3
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Total Current Assets 1943 1893 1939 1885 1897
Cash and Short Term Investments 318 365 418 362 374
Cash & Equivalents 318 365 418 362 374
Total Receivables, Net 652 685 645 661 707
Accounts Receivable - Trade, Net 652 632 645 661 707
Total Inventory 659 627 592 581 553
Prepaid Expenses 314 128 284 281 263
Total Assets 7673 7643 7522 8948 9172
Property/Plant/Equipment, Total - Net 961 961 915 949 975
Goodwill, Net 2701 2688 2584 3858 3944
Intangibles, Net 1862 1903 1875 2100 2228
Other Long Term Assets, Total 206 198 209 156 128
Total Current Liabilities 1374 1170 1296 1241 1372
Accounts Payable 267 279 271 289 277
Accrued Expenses 655 727 711 688 694
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 316 118 246 220 347
Other Current Liabilities, Total 136 46 68 44 54
Total Liabilities 4032 3832 3909 4111 4309
Total Long Term Debt 1842 1826 1737 1807 1872
Long Term Debt 1842 1825 1737 1807 1872
Deferred Income Tax 271 287 246 409 389
Minority Interest -3 1 1 1 1
Other Liabilities, Total 548 548 629 653 675
Total Equity 3641 3811 3613 4837 4863
Common Stock 3 3 3 3 3
Additional Paid-In Capital 6604 6629 6619 6617 6573
Retained Earnings (Accumulated Deficit) 407 456 498 1602 1556
Treasury Stock - Common -2759 -2649 -2663 -2666 -2640
Other Equity, Total -614 -628 -844 -719 -629
Total Liabilities & Shareholders’ Equity 7673 7643 7522 8948 9172
Total Common Shares Outstanding 212.5 215.3 214.9 214.8 215.5
Other Current Assets, Total 88
Capital Lease Obligations 1
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -950 411 -73 256 -1010.9
Cash From Operating Activities 517 657 649 639 499.8
Cash From Operating Activities 119 124 142 133 132.9
Amortization 209 222 192 190 197.9
Deferred Taxes -228 -25 -62 -40 -62
Non-Cash Items 1445 68 250 116 1275.1
Cash Taxes Paid 122 148 82 112 104.7
Cash Interest Paid 70 64 45 30 35.1
Changes in Working Capital -78 -143 200 -16 -33.2
Cash From Investing Activities -138 -358 -1106 -69 -253.3
Capital Expenditures -149 -142 -87 -123 -188
Other Investing Cash Flow Items, Total 11 -216 -1019 54 -65.3
Cash From Financing Activities -329 -379 476 -472 -249.8
Financing Cash Flow Items -21 -36 -56 -40 0
Total Cash Dividends Paid -104 -92 -88 -81 -78.6
Issuance (Retirement) of Stock, Net -144 -149 -129 -151 -222.3
Issuance (Retirement) of Debt, Net -60 -102 749 -200 51.1
Foreign Exchange Effects -24 -19 14 -3 -7.7
Net Change in Cash 26 -99 33 95 -11
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -23 -950 -935 142 69
Cash From Operating Activities -21 517 375 266 93
Cash From Operating Activities 31 119 90 59 29
Amortization 53 209 159 108 55
Deferred Taxes -21 -228 -220 -13 -14
Non-Cash Items 78 1445 1366 62 13
Changes in Working Capital -139 -78 -85 -92 -59
Cash From Investing Activities -37 -138 -109 -83 -43
Capital Expenditures -39 -149 -117 -85 -44
Other Investing Cash Flow Items, Total 2 11 8 2 1
Cash From Financing Activities 17 -329 -168 -162 -10
Financing Cash Flow Items -4 -21 -15 -8 -7
Total Cash Dividends Paid -27 -104 -78 -51 -24
Issuance (Retirement) of Stock, Net -150 -144 -144 -144 -145
Issuance (Retirement) of Debt, Net 198 -60 69 41 166
Foreign Exchange Effects -6 -24 -19 2 -5
Net Change in Cash -47 26 79 23 35
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 11.7083 24788312 -421577 2023-06-30 LOW
Artisan Partners Limited Partnership Investment Advisor 6.3644 13474353 -257843 2023-06-30 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 5.2517 11118606 98024 2023-06-30 LOW
First Eagle Investment Management, L.L.C. Investment Advisor/Hedge Fund 4.5986 9735915 -18910 2023-06-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 4.485 9495526 254642 2023-06-30 LOW
Nuance Investments, LLC Investment Advisor 4.2582 9015249 -1946666 2023-06-30 MED
Janus Henderson Investors Investment Advisor/Hedge Fund 3.6482 7723734 18100 2023-06-30 LOW
Wellington Management Company, LLP Investment Advisor/Hedge Fund 3.2144 6805349 144391 2023-06-30 LOW
T. Rowe Price Associates, Inc. Investment Advisor 3.1773 6726894 -781200 2023-06-30 LOW
Cooke & Bieler, L.P. Investment Advisor 2.4995 5291758 -431880 2023-06-30 LOW
T. Rowe Price Investment Management, Inc. Investment Advisor 2.3855 5050537 -25241 2023-06-30 LOW
Morgan Stanley & Co. LLC Research Firm 2.3196 4910911 -994527 2023-06-30 MED
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 2.2722 4810653 60742 2023-06-30 LOW
Generation Investment Management LLP Investment Advisor/Hedge Fund 2.1867 4629554 -74081 2023-06-30 LOW
Champlain Investment Partners, LLC Investment Advisor 1.8306 3875642 9025 2023-06-30 LOW
Mackenzie Financial Corporation Investment Advisor/Hedge Fund 1.2368 2618474 -1715210 2023-06-30 LOW
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 1.1916 2522902 -5846 2023-06-30 LOW
Invesco Capital Management LLC Investment Advisor 1.1693 2475650 196715 2023-06-30 LOW
Invesco Advisers, Inc. Investment Advisor 1.0633 2251257 -546826 2023-06-30 LOW
American Century Investment Management, Inc. Investment Advisor/Hedge Fund 1.0396 2201024 -625074 2023-06-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Dentsply Company profile

About DENTSPLY SIRONA Inc

DENTSPLY SIRONA Inc. is a manufacturer of professional dental products and technologies. The Company develops, manufactures and markets solutions, including dental equipment and dental consumable products. The Company’s segments include Technologies & Equipment (T&E) and Consumables. The T&E segment is engaged in designing, manufacturing, sales and distribution of its Dental Technology and Equipment Products and Healthcare Consumable Products. Its products include dental implants, computer-aided design/computer-aided manufacturing systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as consumable medical device products. The Consumables segment is engaged in designing, manufacturing, sales and distribution of the Company's Dental Consumable Products, which include preventive, restorative, endodontic and dental laboratory products. It also offers treatment planning and a clear aligner solution delivered directly to a consumer's home.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, DENTSPLY SIRONA Inc revenues increased 27% to $4.25B. Net income totaled $421M vs. loss of $83M. Revenues reflect Technologies & Equipment segment increase of 29% to $2.52B, Consumables segment increase of 25% to $1.73B, United States segment increase of 35% to $1.5B. Net Income reflects Technologies & Equipment segment income increase of 72% to $541M.

Equity composition

Common Stock $.01 Par, 3/11, 200M auth., 162,800,000 issd.,less 21,900,000M shs. in Treas. @ $750.6M. Insiders control 0.29%. PO:11/93, 3.3M shares @ $39 by Goldman Sachs. FY'99 Summ.Qs reflect reclassification. 2/02, 3-for-2 stock split. 7/06, 2-for-1 stock split.

Industry: Medical Equipment, Supplies & Distribution (NEC)

Suite 60W
221 West Philadelphia Street
YORK
PENNSYLVANIA 28277-3607
US

Income Statement

  • Annual
  • Quarterly

News

How to Trade The Triple Top

Welcome to Part 5 of our 7-part Power Patterns series. In this series, we'll be equipping you with the skills to trade some of the most indicative price patterns which occur on any timeframe in every market.

14:13, 27 September 2023
USA flag on the background of stock charts. Financial system in USA

Q4 lookahead: US indices starting to show signs of trouble?

US indices start to draw attention as traders focus on the outlook for Q4.

07:20, 27 September 2023

USD/JPY Climbs Towards Key Highs

USDJPY’s powerful long-term uptrend has been reignited after last week’s sharply contrasting policy statements from the Federal Reserve and Bank of Japan.

11:32, 26 September 2023

EUR/USD tests key support

EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.

14:32, 21 September 2023
Bank of England building

BoE leaves rates unchanged, GBP drops further as investors look for more clarity

The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August

11:45, 21 September 2023
British banknotes and coins photographed directly above. The coins are in a stack, placed on top of the banknotes.

GBP softer after CPI surprise, JPY focused on any further hints from Ueda

GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.

12:42, 20 September 2023

How to Trade The Break & Retest

In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.

11:59, 20 September 2023

People also watch

US100

14,732.90 Price
+0.890% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0039%
Overnight fee time 21:00 (UTC)
Spread 1.8

BTC/USD

27,226.50 Price
+3.570% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 85.00

Oil - Crude

91.37 Price
-1.990% 1D Chg, %
Long position overnight fee 0.0746%
Short position overnight fee -0.0965%
Overnight fee time 21:00 (UTC)
Spread 0.030

XRP/USD

0.52 Price
+1.310% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01192

Still looking for a broker you can trust?

Join the 555.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading